1.00
                                            前日終値:
              $0.9925
            開ける:
              $0.99
            24時間の取引高:
                51,706
            Relative Volume:
              0.03
            時価総額:
                $24.20M
            収益:
              -
            当期純損益:
              -
            株価収益率:
              -
            EPS:
                -
            ネットキャッシュフロー:
                -
            1週間 パフォーマンス:
              +3.43%
            1か月 パフォーマンス:
              -2.91%
            6か月 パフォーマンス:
                +28.39%
            1年 パフォーマンス:
              +0.00%
            Metavia Inc Stock (MTVA) Company Profile
MTVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                MTVA
                            
                             
                        Metavia Inc 
                           | 
                    1.00 | 24.02M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 | 
|---|---|---|---|
| 2025-09-04 | 再開されました | H.C. Wainwright | Buy | 
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy | 
Metavia Inc (MTVA) 最新ニュース
What’s next for MetaVia Inc. stock price2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
MetaVia Inc. stock prediction for this weekJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com
MetaVia Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Real time breakdown of MetaVia Inc. stock performanceJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Why MetaVia Inc. stock could outperform in 2025July 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com
Is it too late to sell MetaVia Inc.Market Growth Review & Free AI Powered Buy and Sell Recommendations - newser.com
How to manage a losing position in MetaVia Inc.July 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Sector ETF performance correlation with MetaVia Inc.Trade Ideas & Daily Oversold Bounce Ideas - newser.com
How MetaVia Inc. stock reacts to bond yields2025 Trading Volume Trends & Real-Time Volume Spike Alerts - newser.com
Ranking MetaVia Inc. among high performing stocks via toolsJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
How to build a dashboard for MetaVia Inc. stockTrade Entry Summary & Free Daily Entry Point Trade Alerts - newser.com
Metavia Inc. Advances Obesity Treatment with New Clinical Study - TipRanks
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting - Lelezard
MetaVia (Nasdaq: MTVA) to present vanoglipel (DA-1241) MASH poster at AASLD Nov 10 - Stock Titan
Metavia Inc (MTVA) 財務データ
        Metavia Inc (MTVA) の財務データはありません。詳細については、他の銘柄を確認してください。
    
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):